|
Unique Study ID
|
AA-AA-000-0000
|
|
Protocol title
|
Protocol Title
|
|
Protocol nickname
|
Protocol Nickname
|
|
Sites (Enrolled / Planned)
|
176 / 190
|
|
Participants (Enrolled / Planned)
|
1301 / 1300
|
|
Date that snapshot was created
|
2019-12-01
|
|
Risk-based monitoring flag
|
Y
|
|
Study Status
|
Active
|
|
Product
|
Product
|
|
Phase
|
P3
|
|
Therapeutic Area
|
Therapeutic Area
|
|
Indication
|
Protocol Indication
|
|
Protocol type
|
Investigator Sponsored
|
|
Protocol row ID
|
1-1G9113
|
|
Protocol product number
|
123
|
|
# of enrolled sites from GILDA
|
176
|
|
# of enrolled participants from GILDA
|
1301
|
|
First-patient first visit date
|
2003-01-01 00:00:00
|
|
Estimated first-patient first visit date from GILDA
|
2003-01-01 00:00:00
|
|
Last-patient first visit date
|
2020-06-01 00:00:00
|
|
Estimated last-patient first visit date from GILDA
|
2020-06-01 00:00:00
|
|
Last-patient last visit date
|
2021-06-01 00:00:00
|
|
Estimated last-patient last visit date from GILDA
|
2021-06-01 00:00:00
|